Lowering β-Amyloid Levels Rescues Learning and Memory in a Down Syndrome Mouse Model

William J. Netzer, Craig Powell, Yi Nong et al. · 2010

Read Lowering β-Amyloid Levels Rescues Learning and Memory in a Down Syndrome Mouse Model by William J. Netzer, Craig Powell, Yi Nong et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010943.txt.

Description

William Netzer, Craig Powell, Yi Nong and co-authors published this Down syndrome study in PLOS ONE in 2010. People with Down syndrome carry high levels of beta-amyloid, the protein that builds plaques in Alzheimer's disease, throughout their lives. That load is blamed for dementia in older adults with the condition, but whether it also harms learning in the young was unknown.

The authors gave young mice that model Down syndrome a drug that blocks an enzyme needed to make beta-amyloid. Lowering the protein corrected the learning problems typical of these mice. Netzer and colleagues argue the same protein may drag down thinking long before dementia begins. Their result raises the possibility that amyloid-lowering treatments, developed for Alzheimer's, could also help younger people with Down syndrome learn.

Catalog record

CREATORWilliam J. Netzer, Craig Powell, Yi Nong et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010943

Browse the full library · About the Tower of Babel